| Literature DB >> 3144581 |
J S Duncan1, S D Shorvon, M R Trimble.
Abstract
A prospective, double-blind, placebo-controlled investigation of possible withdrawal symptoms from phenytoin, carbamazepine and sodium valproate is reported in patients with active epilepsy, on combination therapy. There was an increase in seizures on reduction and withdrawal of carbamazepine, but there was no convincing evidence of withdrawal symptoms from any of these drugs.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3144581 PMCID: PMC1033195 DOI: 10.1136/jnnp.51.7.924
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154